Hiromitsu Yamamoto

3.1k total citations
47 papers, 2.4k citations indexed

About

Hiromitsu Yamamoto is a scholar working on Pharmaceutical Science, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiromitsu Yamamoto has authored 47 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pharmaceutical Science, 14 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiromitsu Yamamoto's work include Advanced Drug Delivery Systems (28 papers), Nanoparticle-Based Drug Delivery (11 papers) and Inhalation and Respiratory Drug Delivery (9 papers). Hiromitsu Yamamoto is often cited by papers focused on Advanced Drug Delivery Systems (28 papers), Nanoparticle-Based Drug Delivery (11 papers) and Inhalation and Respiratory Drug Delivery (9 papers). Hiromitsu Yamamoto collaborates with scholars based in Japan, Germany and China. Hiromitsu Yamamoto's co-authors include Yoshiaki Kawashimà, Hirofumi Takeuchi, Alf Lamprecht, Tomoaki Hino, Toshiyuki Niwa, Yoshio Matsui, Yasunori Sato, Kohei Tahara, Nathalie Ubrich and Philippe Maincent and has published in prestigious journals such as Journal of Controlled Release, Journal of Pharmacology and Experimental Therapeutics and International Journal of Pharmaceutics.

In The Last Decade

Hiromitsu Yamamoto

45 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiromitsu Yamamoto Japan 23 1.4k 735 715 237 227 47 2.4k
Nathalie Ubrich France 26 1.4k 1.0× 498 0.7× 932 1.3× 162 0.7× 296 1.3× 39 2.5k
Elke Walter Switzerland 24 769 0.5× 1.2k 1.7× 734 1.0× 205 0.9× 415 1.8× 34 2.9k
Brigitta Loretz Germany 30 791 0.6× 911 1.2× 663 0.9× 170 0.7× 380 1.7× 97 2.5k
Dolores Torres Spain 29 1.6k 1.1× 1.0k 1.4× 876 1.2× 88 0.4× 345 1.5× 62 2.9k
Hajime Toguchi Japan 26 1.4k 1.0× 688 0.9× 633 0.9× 82 0.3× 262 1.2× 61 2.6k
Christiane Damgé France 25 1.2k 0.9× 671 0.9× 559 0.8× 84 0.4× 186 0.8× 55 2.3k
Noémi Csaba Spain 30 1.1k 0.8× 1.1k 1.6× 797 1.1× 84 0.4× 369 1.6× 75 2.7k
Begoña Seijo Spain 27 1.6k 1.1× 876 1.2× 996 1.4× 123 0.5× 290 1.3× 60 3.2k
Stanley S. Davis United Kingdom 14 1.4k 1.0× 659 0.9× 542 0.8× 65 0.3× 182 0.8× 18 2.4k
Driton Vllasaliu United Kingdom 28 830 0.6× 907 1.2× 792 1.1× 104 0.4× 448 2.0× 63 2.6k

Countries citing papers authored by Hiromitsu Yamamoto

Since Specialization
Citations

This map shows the geographic impact of Hiromitsu Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromitsu Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromitsu Yamamoto more than expected).

Fields of papers citing papers by Hiromitsu Yamamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromitsu Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromitsu Yamamoto. The network helps show where Hiromitsu Yamamoto may publish in the future.

Co-authorship network of co-authors of Hiromitsu Yamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromitsu Yamamoto. A scholar is included among the top collaborators of Hiromitsu Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromitsu Yamamoto. Hiromitsu Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takahashi, Chisato & Hiromitsu Yamamoto. (2016). PB-15STEM observation for understanding antibacterial mechanism of polymeric particles against biofilm. Microscopy. 65(suppl 1). i31–i31. 1 indexed citations
2.
Tsukada, Yusuke, Hiroyuki Tsujimoto, Takayuki Sugimoto, et al.. (2013). Development of Oral Formulation Technology for Nucleic Acid Drug by Using PLGA Nanoparticles as DDS Carriers. Journal of the Society of Powder Technology Japan. 50(7). 513–518. 1 indexed citations
3.
Fujimura, Takeki, Akio Mitani, Mitsuo Fukuda, et al.. (2013). Irradiation with a low-level diode laser induces the developmental endothelial locus-1 gene and reduces proinflammatory cytokines in epithelial cells. Lasers in Medical Science. 29(3). 987–994. 26 indexed citations
4.
Tahara, Kohei, Hiromitsu Yamamoto, & Yoshiaki Kawashimà. (2011). Interaction of Biodegradable Polymeric Nanospheres with Cells : the Effect of Surface Properties. Journal of the Society of Powder Technology Japan. 48(3). 173–179. 2 indexed citations
5.
Tahara, Kohei, et al.. (2010). Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells. Journal of Microencapsulation. 28(1). 29–36. 20 indexed citations
6.
Sun, Shaoping, Na Liang, Hongze Piao, et al.. (2010). Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: Formulation, characterization andin vivoevaluation. Journal of Microencapsulation. 27(6). 471–478. 54 indexed citations
7.
Nakano, Koji, Yuichi Tozuka, Hiromitsu Yamamoto, Yoshiaki Kawashimà, & Hirofumi Takeuchi. (2007). A novel method for measuring rigidity of submicron-size liposomes with atomic force microscopy. International Journal of Pharmaceutics. 355(1-2). 203–209. 59 indexed citations
8.
Thongborisute, Jringjai, Hirofumi Takeuchi, Hiromitsu Yamamoto, & Yoshiaki Kawashimà. (2006). Visualization of the Penetrative and Mucoadhesive Properties of Chitosan and Chitosan-Coated Liposomes Through the Rat Intestine. Journal of Liposome Research. 16(2). 127–141. 32 indexed citations
9.
Lamprecht, Alf, Hiromitsu Yamamoto, Nathalie Ubrich, et al.. (2005). FK506 Microparticles Mitigate Experimental Colitis with Minor Renal Calcineurin Suppression. Pharmaceutical Research. 22(2). 193–199. 28 indexed citations
10.
Takeuchi, Hirofumi, Yuji Matsui, Hikaru Sugihara, Hiromitsu Yamamoto, & Yoshiaki Kawashimà. (2005). Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. International Journal of Pharmaceutics. 303(1-2). 160–170. 138 indexed citations
11.
Yamamoto, Hiromitsu, et al.. (2004). Engineering of Poly (DL-lactic-co-glycolic acid) Nano-composite Particle for Dry Powder Inhalation Dosage Forms of Insulin with Spray Fluidized Bed Granulating System. Journal of the Society of Powder Technology Japan. 41(7). 514–521. 6 indexed citations
12.
Lamprecht, Alf, Hiromitsu Yamamoto, Hirofumi Takeuchi, & Yoshiaki Kawashimà. (2004). pH-sensitive microsphere delivery increases oral bioavailability of calcitonin. Journal of Controlled Release. 98(1). 1–9. 47 indexed citations
13.
Sato, Yasunori, Yoshiaki Kawashimà, Hirofumi Takeuchi, & Hiromitsu Yamamoto. (2004). In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. International Journal of Pharmaceutics. 275(1-2). 97–107. 82 indexed citations
14.
Kawashimà, Yoshiaki, et al.. (2003). Simultaneous particulate design of primary and agglomerated crystals of steroid by spherical agglomeration in liquid for dry powder inhalation. Powder Technology. 130(1-3). 290–297. 11 indexed citations
15.
Takeuchi, Hirofumi, Yoshio Matsui, Hiromitsu Yamamoto, & Yoshiaki Kawashimà. (2003). Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. Journal of Controlled Release. 86(2-3). 235–242. 226 indexed citations
16.
Takeuchi, Hirofumi, Hiroyuki Kojima, Hiromitsu Yamamoto, & Yoshiaki Kawashimà. (2001). Evaluation of the anti-tumour activity of liposomal doxorubicin coated with hydrophilic polymers in tumour-bearing mice. 11(4). 271–274. 1 indexed citations
17.
Lamprecht, Alf, Nathalie Ubrich, Hiromitsu Yamamoto, et al.. (2001). Biodegradable Nanoparticles for Targeted Drug Delivery in Treatment of Inflammatory Bowel Disease. Journal of Pharmacology and Experimental Therapeutics. 299(2). 775–781. 291 indexed citations
18.
Yamamoto, Hiromitsu, Hirofumi Takeuchi, Tomoaki Hino, & Yoshiaki Kawashimà. (2000). Mucoadhesive Liposomes : Physicochemical Properties and Release Behavior of Water-Solubule Drugs from Chitosan-Coated Liposomes.. 10(1). 63–68. 13 indexed citations
19.
Kawashimà, Yoshiaki, et al.. (2000). In vitro inhalation behavior of spherically agglomerated steroid particles with carrier lactose. Advanced Powder Technology. 11(3). 323–332. 7 indexed citations
20.
Takeuchi, Hirofumi, Hiromitsu Yamamoto, Toshiyuki Niwa, Tomoaki Hino, & Yoshiaki Kawashimà. (1996). Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes. Pharmaceutical Research. 13(6). 896–901. 324 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026